Oriana Ciacio is an expert in Surgery at Hôpital Paul-Brousse (France). Oriana Ciacio has authored 137 publications, the most recent in 2026, and is an investigator in 2 clinical trials, 1 of them ongoing. SLR score: 256 (community average: 125). How the SLR is computed.

LeadR Profile

Oriana Ciacio Hôpital Paul-Brousse France
256 ScienceLeadR Reputation 256
Network Map

Surgery

Subspecialties: Hepatology - Transplantation - Gastroenterology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2009 - 2026

Source: PubMed

Hôpital Paul-Brousse

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 137

Citations

Citations: 2 149 1st author: 3 Last author: 0 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.
PMID 42561547 — pilots, cytoreduction surgical procedures, drug therapy, liver, hepatectomy, neoplasm metastasis, prospective studies, chemotherapy
Cancer Treat Rev20260
Right (H145678) and Left (H123458) 6-Segmentectomies for Malignant Liver Tumors: A Retrospective Analysis of 237 Cases Using Contemporary Surgery Quality Indicators.
PMID 42522084 — neoplasms, mastectomy, segmental, liver, general surgery, cholangiocarcinoma, survival rate
Ann Surg20260
ASO Visual Abstract: Is R1 Extended Liver Resection for Locally Advanced Intrahepatic Cholangiocarcinoma Justified? Nodal Status Not Margin Drives Prognosis.
PMID 42406213 — liver, prognosis, cholangiocarcinoma, intrahepatic cholangiocarcinoma
Ann Surg Oncol20260
Is R1 Extended Liver Resection for Locally Advanced Intrahepatic Cholangiocarcinoma Justified? Nodal Status Not Margin Drives Prognosis.
PMID 42371322 — liver, morbidity, prognosis, cholangiocarcinoma, intrahepatic cholangiocarcinoma
Ann Surg Oncol20260
Gallstones: Physiopathology and treatment of cholelithiasis (part 1).
PMID 42203606 — bile, gallstones, cholecystitis, gallbladder, risk management, cholesterol, lithiasis, cholelithiasis, therapeutics, general surgery
J Visc Surg20260

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1
Phase 2 1

By status:

Active not recruiting 1
Completed 1

By type:

Interventional 2

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 9

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
JAK1 inhibitor treatment of inflammatory liver adenomas
2023-505278-13-00 — estrogens, neoplasms, contraception, liver, adenoma, liver cell, histology, adenoma, therapeutics, male, women
Phase 2Active not recruiting2024

LeadR Networks

Main global connection map